Search
for
Did you mean Patient-Reported Outcome Measures?
Sort by
Research 30 of 1000+
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Outcome measure instruments for the assessment and treatment of androgenetic alopecia: A scoping review
- An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- PSS21 GAP ANALYSIS FOR PATIENT-REPORTED OUTCOMES MEASURES FOR ALOPECIA
- Content validity of five single‐item instruments in adolescents with alopecia areata
- The Spectrum of Health Domains Important to Lupus Patients Early Development of a Disease Activity Patient Reported Outcome.
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- Development and validation of a patient‐reported outcome measure for hair loss treatment: The HAIR‐Q
- Alopecia Areata–Specific Patient-Reported Outcome Measures
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Patient prioritisation of items to develop the Patient‐Reported Impact of Dermatological Diseases measure: A global Delphi study
- A Systematic Review of 207 Studies Describing Validation Aspects of the Dermatology Life Quality Index
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
- A new self‐reported measure of disease severity of scalp hair loss in alopecia areata
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- The role of injectable <i>regenerative</i> treatments in the management of <i>female pattern hair loss</i> and their impact on patient-reported body image
- Signposts to the Promised Land in Alopecia Areata
- Scalp cooling versus standard cold-cap in preventing chemotherapy-induced alopecia in patients with localized breast cancer: ICELAND protocol, a randomized controlled trial and economic evaluation
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- The Efficiency of Platelet-Rich Plasma (PRP) in Treating Post-Burn and Surgical Scars: A Meta-Analysis Study
- Measuring Patient Quality of Life Following Treatment for Alopecia
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients